Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Current Protocols in Immunology
|
February 9, 2013
Comparing individual NK cell activity in vitro
Heidi Sierich, Thomas Eiermann
Trends in Genetics : TIG
|
May 19, 2021
Multiple sclerosis: doubling down on MHC
Roland Martin, Mireia Sospedra, Thomas Eiermann, et al.
Human Immunology
|
September 20, 2011
Assessment of physiologic natural killer cell cytotoxicity in vitro
Heidi Duske, Andreas Sputtek, Thomas Binder, et al.
Transplantation
|
March 13, 2012
In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor
Florian W R Vondran, Thomas Eiermann, Friedrich Thaiss, et al.
Clinical Transplantation
|
January 29, 2015
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction
Anja M Lehnhardt, Maximiliane Strecker, Thomas Eiermann, et al.
Annals of the New York Academy of Sciences
|
February 9, 2005
Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes
Silvia Rathmann, Tarvo Rajasalu, Silke Rosinger, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 29, 2012
Elevated serum levels of B-cell activating factor in pediatric renal transplant patients
Anja Lehnhardt, Franziska Dunst, Michael van Husen, et al.
Annals of the New York Academy of Sciences
|
December 18, 2003
Relationship between T and B cell responses to proinsulin in human type 1 diabetes
Ivana Durinovic-Belló, Nicola Maisel, Michael Schlosser, et al.
Diabetes
|
November 25, 2005
Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals
Ivana Durinovic-Belló, Eva Jelinek, Michael Schlosser, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
May 16, 2013
Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib
Martina Koch, Christian Gräser, Anja Lehnhardt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Current Protocols in Immunology
|
February 9, 2013
Comparing individual NK cell activity in vitro
Heidi Sierich, Thomas Eiermann
Trends in Genetics : TIG
|
May 19, 2021
Multiple sclerosis: doubling down on MHC
Roland Martin, Mireia Sospedra, Thomas Eiermann, et al.
Human Immunology
|
September 20, 2011
Assessment of physiologic natural killer cell cytotoxicity in vitro
Heidi Duske, Andreas Sputtek, Thomas Binder, et al.
Transplantation
|
March 13, 2012
In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor
Florian W R Vondran, Thomas Eiermann, Friedrich Thaiss, et al.
Clinical Transplantation
|
January 29, 2015
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction
Anja M Lehnhardt, Maximiliane Strecker, Thomas Eiermann, et al.
Annals of the New York Academy of Sciences
|
February 9, 2005
Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes
Silvia Rathmann, Tarvo Rajasalu, Silke Rosinger, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 29, 2012
Elevated serum levels of B-cell activating factor in pediatric renal transplant patients
Anja Lehnhardt, Franziska Dunst, Michael van Husen, et al.
Annals of the New York Academy of Sciences
|
December 18, 2003
Relationship between T and B cell responses to proinsulin in human type 1 diabetes
Ivana Durinovic-Belló, Nicola Maisel, Michael Schlosser, et al.
Diabetes
|
November 25, 2005
Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals
Ivana Durinovic-Belló, Eva Jelinek, Michael Schlosser, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
May 16, 2013
Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib
Martina Koch, Christian Gräser, Anja Lehnhardt, et al.
Page
of 3